No CrossRef data available.
Article contents
Author's reply
Published online by Cambridge University Press: 13 June 2014
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Letters to the Editor
- Information
- Copyright
- Copyright © Cambridge University Press 1992
References
1.Johnson, BA, McCann, J, Johnson, BA. Toxicity of lofepramine in heart disease. Ir J Psychol Med 1990; 7: 142–3.CrossRefGoogle Scholar
2.Kelleher, MJ, Daly, M, Casey, P. Thoughts on suicide and the prescription of tricyclics. Ir J Psychiat 1990; 11(1): 8–11.Google Scholar
3.Klerman, GL. The psychiatric patient's right to effective treatment: implications of Osheroff -v- Chestnut Lodge. Am J Psychiatry 1990; 147: 409–18.Google ScholarPubMed
4.Sloan, JH, Rivara, FP, Reay, DTet al.Firearm regulations and rates of suicide. A comparison of two metropolitan areas. N Engl J Med 1990; 322: 369–73.CrossRefGoogle ScholarPubMed
5.O'Shea, B, Falvey, J, Rahill, M. Aspects of self-harm. In: O'Shea, B, editor. Essays in Psychiatry. Vol 2. Dublin: EHB Print, 1989.Google Scholar
6.Creelman, W, Goethe, JW. Guidelines for the pharmacological management of depression. Connecticut Med 1985; 49: 565–9.Google ScholarPubMed
7.Takahashi, R, Sakuma, A, Hara, T, et al.Comparison of efficacy of amoxapine and imipramine in a multi-clinic double-blind study using the WHO Schedule for a Standard Assessment of Patients with Depressive Disorders. J. Inter Med Res 1979; 7–18.Google Scholar
8.Cawley, RH. Educating the psychiatrist of the 21st century. Br J Psychiatry 1990; 157: 174–81.CrossRefGoogle Scholar